NSETrading Window22 Jun 2026 · 22 Jun 2026, 04:59 pm
Trading Window
Dr. Reddy's Laboratories Limited · DRREDDY
✦ AI Summary
Dr. Reddy's Laboratories Limited announced a Board meeting on July 22, 2026, to consider its Un-audited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026. In accordance with SEBI regulations, the trading window for dealing in the company's securities will be closed from June 24, 2026, to July 24, 2026. This routine intimation ensures compliance and prevents insider trading prior to the financial results disclosure.
Analysis Scores
Earnings Impact5/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Dr. Reddy's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
DRREDDY_22062026165915_SE_intimation_Trading_window_closure_22062026_signed.pdf
View document text
Dr. Reddy's Laboratories Ltd.
8-2-337, Road No. 3, Banjara Hills
Hyderabad – 500 034, Telangana, India
CIN: L85195TG1984PLC004507
Tel: + 91 40 4900 2900
Fax: + 91 40 4900 2999
Email: mail@drreddys.com
Web: www.drreddys.com
June 22, 2026
National Stock Exchange of India Ltd. (Scrip Code: DRREDDY)
BSE Limited (Scrip Code: 500124)
New York Stock Exchange Inc. (Stock Code: RDY)
NSE IFSC Ltd. (Stock Code: DRREDDY)
Dear Sir/Madam,
Sub: Intimation regarding Board meeting and Trading window closure
Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015, we hereby inform you that a meeting of the Board of Directors of the Company will be held on
Wednesday, July 22, 2026, inter alia, to consider the Un-audited Standalone and Consolidated Financial
Results of the Company for the quarter ending on June 30, 2026.
Further, kindly note that, under the provisions of the SEBI (Prohibition of Insider Trading) Regulations,
2015, the trading window for dealing in the securities of the Company will be closed from June 24, 2026,
to July 24, 2026 (both days inclusive).
This is for your information and records.
Thanking you,
Yours faithfully,
For Dr. Reddy’s Laboratories Limited
K Randhir Singh
Company Secretary, Compliance Officer & Head-CSR